Pyrexi, brystsmerter, asteni, perifert ødem, utilpashed.
Pyrexia, chest pain, asthenia, peripheral oedema, malaise.De mest almindelige symptomer er kulderystelser, hovedpine,kvalme, pyrexi, rødmen og træthed.
The most common symptoms have been rigors, headache,nausea, pyrexia, flushing and fatigue.Kuldegysninger, pyrexi, asteni, træthed*, influenzalignende sygdom.
Chills, pyrexia, asthenia, fatigue*, Influenza-like illness.De hyppigste bivirkninger(som ses hos flere end 1 ud af 10 patienter)var pyrexi(feber), diarré og opkastning.
The most common side effects(seen in more than 1 patient in 10)were pyrexia(fever), diarrhoea and vomiting.Pyrexi, brystsmerter, perifert ødem, utilpashed, kulderystelse, unormal følelse, varme følelse, irritabel, smerte, tørhed.
Pyrexia, chest pain, peripheral oedema, malaise, chills, abnormal feeling, feeling hot, irritability, pain, xerosis.De hyppigste var milde infusionsrelaterede virkninger, som hovedsageligt omfattede kulderystelser, pyrexi, rødmen, hovedpine, kvalme og dyspnø.
The most frequent were mild infusion-related reactions that mainly included rigors, pyrexia, flushing, headache, nausea, and dyspnoea.Træthed, pyrexi, brystsmerter, erytem på injektionsstedet, smerte på injektionsstedet, reaktion på injektionsstedet uspecificeret.
Fatigue, pyrexia, chest pain, injection site erythema, injection site pain, injection site reaction unspecified.Infusionsrelaterede reaktioner, der blev rapporteret som svære hos mere end 1 patient, omfattede pyrexi, reduceret iltmætning, takykardi, cyanose og hypotension.
Those IARs reported as severe in more than 1 patient included pyrexia, decreased oxygen saturation, tachycardia, cyanosis and hypotension.I begge studier var pyrexi og hovedpine de hyppigst rapporterede bivirkninger, der muligvis kan tilskrives lægemidlet.
Pyrexia and headache were the most frequently reported adverse events potentially related to the medicinal product in both studies.De mest almindeligt indberettede uønskede reaktioner, der forekom hyppigere ved vaccine end ved placebo, var pyrexi(20, 9%), diaré(17, 9%) og opkastning 10.
The most commonly reported adverse reactions that occurred more frequently with vaccine than with placebo were pyrexia(20.9%), diarrhoea(17.6%) and vomiting 10.1.Asteni; periferalt ødem; pyrexi; træthed; inflammation i slimhinderne; smerter; influenza- lignende symptomer; brystsmerter; kulderystelser.
Asthenia; Oedema peripheral; Pyrexia; Fatigue; Mucosal inflammation; Pain; Influenza like illness; Chest pain; Chills.Erfaringer efter markedsføringen med infusionsrelaterede reaktioner afslørede regelmæssig indberetning af tilfælde af pyrexi, kulderystelser og opkastning, for det meste af mild til moderat intensitet.
Post-marketing experience of infusion associated reactions revealed reporting of pyrexia, chills and vomiting, mostly mild to moderate in intensity.Milde reaktioner på injektionsstedet(erythema, ømhed, misfarvning af huden eller opsvulmen, smerter, ekstravasation kan medføre cellulitis og hudulceration), utilpashed, brystsmerter,kulderystelser, pyrexi.
Mild injection site reactions(erythema, tenderness, skin discoloration or swelling, pain, extravasation, can result in cellulitis and skin ulceration), malaise, chest pain,chills, pyrexia.De hyppigste bivirkninger ved Advate(som kunne observeres hos mellem 1 og 10 patienter ud af 100) er svimmelhed,hovedpine, pyrexi(feber) og tilstedeværelse af antistoffer over for faktor VIII.
The most common side effects with Advate(seen in between 1 to 10 patients in 100) are dizziness,headache, pyrexia(fever) and the presence of antibodies against factor VIII.Pyrexi, reaktion på injektionsstedet Kulderystelser, slaphed, smerter, inflammation på infusionsstedet, ødem på injektionsstedet, smerter på injektionsstedet, kløe på injektionsstedet, hævelse på injektionsstedet, implantatmigration.
Pyrexia, injection site reaction Rigors, asthenia, pain, infusion site inflammation, injection site oedema, injection site pain, injection site pruritus, injection site swelling, migration of implant.Alvorlige infusionsreaktioner er rapporteret som usædvanlige;de rapporterede symptomer inkluderer pyrexi, kulderystelser, takykardi, urticaria, kvalme/ opkastning, angioneurotisk ødem med strubeforsnævring, stridor og hævet tunge.
Serious infusion reactions have been reported uncommonly;symptoms reported include pyrexia, rigors, tachycardia, urticaria, nausea/ vomiting, angioneurotic oedema with throat tightness, stridor and swollen tongue.De hyppigste bivirkninger ved Aldurazyme hos patienter over fem år(som ses hos flere end 1 ud af 10 patienter) er hovedpine, kvalme, mavesmerter, udslæt, artropati(ledskader), artralgi(ledsmerter), rygsmerter, smerter i ekstremiteterne(hænder og fødder),rødme, pyrexi(feber) og reaktioner på infusionsstedet.
The most common side effects with Aldurazyme in patients over the age of five(seen in more than 1 patient in 10) are headache, nausea(feeling sick), abdominal(tummy) pain, rash, arthropathy(damage to the joints), arthralgia(joint pain), back pain, pain in the extremities(hands and feet),flushing, pyrexia(fever) and reactions at the site of the infusion.Andre bivirkninger observeres i sjældne tilfælde, såsom dysgeusi(smagsforstyrrelser), kvalme,reaktioner på injektionsstedet, pyrexi(feber), allergiske eller anafylaktiske(alvorlige allergiske) reaktioner, unormalt blodtryk, svimmelhed, kløe og udslæt.
Other side effects seen in rare cases were dysgeusia(taste disturbances), nausea,reactions at the injection site, pyrexia(fever), allergic or anaphylactic(severe allergic) reactions, abnormal blood pressure, dizziness, pruritus(itching) and rash.De hyppigste bivirkninger ved Elaprase(som ses hos mere end 1 ud af 10 patienter)var forbundet med infusionen, herunder hudreaktioner(udslæt, kløe), pyrexi(feber), hovedpine, hypertension(forhøjet blodtryk) og hævelse på infusionsstedet.
The most common side effects with Elaprase(seen in more than 1 in 10 patients) were related to the infusion,including skin reactions(rash or itching), pyrexia(fever), headache, hypertension(high blood pressure) and swelling at the site of the infusion.Infusionsrelaterede reaktioner hos patienter, der er behandlet med Myozyme i kliniske undersøgelser og” Expanded Access Programs”, som er indberettet for mere end 1 patient, omfattede udslæt, rødmen,urticaria, pyrexi, hoste, takykardi, reduceret iltmætning, opkastning, tachypnoea, uro, forhøjet blodtryk, cyanose, hypertension, irritabilitet, bleghed, pruritus, kløgning, kulderystelser, tremor, hypotension, øget hjertefrekvens, bronkospasmer, erytem, ansigtsødem, varm fornemmelse, hovedpine, hyperhidrose, øget tåredannelse, livedo reticularis, kvalme, periorbitalt ødem, rastløshed 5 og hvæsende vejrtrækning.
IARs in patients treated with Myozyme in clinical studies and expanded access programs and reported in more than 1 patient included rash, flushing,urticaria, pyrexia, cough, tachycardia, decreased oxygen saturation, vomiting, tachypnea, agitation, increased blood pressure, cyanosis, hypertension, irritability, pallor, pruritus, retching, chills, tremor, hypotension, heart rate increased, bronchospasm, erythema, face edema, feeling hot, headache, hyperhidrosis, lacrimation increased, livedo reticularis, nausea, periorbital edema, restlessness and wheezing.De hyppigst indberettede bivirkninger ved TRISENOX(set hos mellem 1 og 10 patienter ud af hver 100) er neutropeni(for få hvide blodlegemer), trombocytopeni(for få blodplader), hyperglykæmi(for højt blodsukker), hypokalæmi(for lavt indhold af kalium i blodet), paræstesi(prikken), brystsmerter,dyspnø(stakåndethed), knoglesmerter, artralgi(ledsmerter), pyrexi(feber), træthed, forlænget QT- interval på et elektrokardiogram(uregelmæssig hjerterytme) samt øget alanin- aminotransferase og aspartat- aminotransferase leverenzymer.
The most commonly reported side effects with TRISENOX(seen in between 1 and 10 patients in 100) are neutropenia(low levels of white blood cells), thrombocytopenia(low levels of platelets), hyperglycaemia(raised blood sugar levels), hypokalaemia(low blood potassium levels), paraesthesia(pins and needles), pleuritic pain(chest pain), dyspnoea(breathlessness), bone pain,arthralgia(joint pain), pyrexia(fever), fatigue(tiredness), prolonged QT interval on an electrocardiogram(irregular heart beat), and increased levels of alanine aminotransferase and aspartate aminotransferase liver enzymes.De hyppigste uønskede hændelser(ADR' er) var: hovedpine, kvalme, mavesmerter, udslæt, arthralgi, rygsmerter, smerter i ekstremiteter,flushing, pyrexi, reaktioner på infusionsstedet, forhøjet blodtryk, nedsat iltmætning, takykardi og kulderystelser.
The most frequent adverse drug reactions(ADRs) were: headache, nausea, abdominal pain, rash, arthralgia, backpain, pain at extremity,flushing, pyrexia, infusion site reactions, blood pressure increased, oxygen saturation decreased tachycardia and chills.
Resultater: 22,
Tid: 0.0382
De mest almindelige alvorlige bivirkninger var: virusinfektion (2%), hovedpine (2%), anæmi (2%) og pyrexi (2%).
Pyrexi hos hunde
Feber, omhandlet medicinsk som pyreksi, kan defineres som en højere end normal kropstemperatur hos hunde.
Andre betingelser for feber omfatter pyrexi og kontrolleret hypertermi.
De hyppigst rapporterede bivirkninger hos personer behandlet med polatuzumab vedotin i kombination med BR inkluderede anæmi, trombocytopeni, neutropeni, træthed, diarré, kvalme og pyrexi.
De hyppigst rapporterede bivirkninger hos personer behandlet med Polivy i kombination med BR inkluderede anæmi, trombocytopeni, neutropeni, træthed, diarré, kvalme og pyrexi.
De mest rapporterede SAE'er var hypertension (9%), viral gastroenteritis (9%), pyrexi (9%) og øvre luftvejsinfektion (9%).
Common adverse reactions include nausea, pyrexia and headache.
Enthusiastically unsober pyrexia paralyzingly preactivates until the negatively customary chapin.
Pyrexia correlates with infarct size and severity.
Investigating and managing pyrexia of unknown origin in adults.
Pyrexia stimulates the thalamus and can cause tachypnoea.
Pyrexia was a consistent feature in infected pigs.
Remember, pyrexia or leucocytes are not specific for bacterial infection.
Pyrexia was predominantly controlled with paracetamol and tepid sponging.
No other clinical signs or pyrexia were recorded.
Antipyratic effect was studied by Brewer’s yeast-induced pyrexia in rats.
Vis mere